Document is current
Any future updates will be listed below
-
Authors
Denning, Amanda E. https://orcid.org/0009-0005-2531-9346
Ittyerah, Ranjit
Levorse, Lisa M.
Sadeghpour, Niyousha
Athalye, Chinmayee
Chung, Eunice
Ravikumar, Sadhana
Dong, Mengjin
Duong, Michael Tran
Li, Yue
Ilesanmi, Ademola
Sreepada, Lasya P.
Sabatini, Philip
Lowe, MaKayla
Bahena, Alejandra
Zablah, Jamila
Spencer, Barbara E.
Watanabe, Ryohei
Kim, Boram
Sørensen, Maja Højvang
Khandelwal, Pulkit
Brown, Christopher
Hrybouski, Stanislau
Xie, Sharon X.
de Flores, Robin
Robinson, John L.
Schuck, Theresa
Ohm, Daniel T.
Arezoumandan, Sanaz
Porta, Sílvia
Detre, John A.
Insausti, Ricardo
Wisse, Laura E. M.
Das, Sandhitsu R.
Irwin, David J.
Lee, Edward B.
Wolk, David A.
Yushkevich, Paul A.
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01 AG069474, RF1 AG056014, P30 AG072979, P01 AG066597, U19 AG062418, R01 AG075276, R01 AG070592, T32 AG076411)
Lunds Universitet
National Institute of Neurological Disorders and Stroke (R25-NS065745, R01-NS109260)
Alzheimer's Association (AACSF-23-1152241, AARF-21- 48972)
- License Information
-
More Information
Article History
Received: 8 May 2024
Revised: 7 August 2024
Accepted: 15 August 2024
First Online: 3 September 2024
Declarations
:
: D.A.W has served as a paid consultant to Eli Lilly, GE Healthcare, and Qynapse. He serves on a DSMB for Functional Neuromodulation and GSK. He is a site investigator for a clinical trial sponsored by Biogen. D.J.I. is member of science advisory board of Denali Therapeutics. S.R.D. received consultation fees from Rancho Biosciences and Nia Therapeutics. The other authors have nothing to disclose.
: Where possible, pre-consent during life and, in all cases, next-of-kin consent at death was given. Imaging studies were approved by the Institutional Review Board at the University of Pennsylvania and were in accordance with the Declaration of Helsinki.
